 David Douin
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 5 | 2021 | 819 | 0.780 |
Why?
| | Positive-Pressure Respiration | 1 | 2021 | 99 | 0.690 |
Why?
| | Anesthetics, Inhalation | 1 | 2021 | 45 | 0.680 |
Why?
| | Propofol | 1 | 2021 | 86 | 0.660 |
Why?
| | Esophageal Fistula | 1 | 2020 | 20 | 0.650 |
Why?
| | Tissue Plasminogen Activator | 1 | 2021 | 231 | 0.630 |
Why?
| | Respiration, Artificial | 7 | 2022 | 667 | 0.590 |
Why?
| | Hospitalization | 11 | 2022 | 2219 | 0.580 |
Why?
| | Anesthesia | 1 | 2021 | 226 | 0.550 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2019 | 166 | 0.550 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 319 | 0.490 |
Why?
| | Wounds and Injuries | 2 | 2021 | 764 | 0.490 |
Why?
| | Neoplasms | 2 | 2021 | 2701 | 0.300 |
Why?
| | Lung | 1 | 2021 | 4086 | 0.290 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 132 | 0.220 |
Why?
| | Hyperoxia | 2 | 2021 | 90 | 0.210 |
Why?
| | Immunocompromised Host | 2 | 2022 | 207 | 0.200 |
Why?
| | Hospital Mortality | 3 | 2022 | 916 | 0.190 |
Why?
| | Immunization, Secondary | 1 | 2022 | 88 | 0.180 |
Why?
| | Humans | 22 | 2022 | 138651 | 0.180 |
Why?
| | Anesthesia, Intravenous | 1 | 2021 | 24 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 2 | 2021 | 496 | 0.170 |
Why?
| | Anesthetics, Intravenous | 1 | 2021 | 60 | 0.170 |
Why?
| | Postoperative Period | 1 | 2021 | 355 | 0.170 |
Why?
| | Adult | 12 | 2022 | 38296 | 0.160 |
Why?
| | Oxygen | 2 | 2021 | 967 | 0.160 |
Why?
| | Organ Transplantation | 1 | 2022 | 252 | 0.150 |
Why?
| | Esophagectomy | 1 | 2020 | 132 | 0.150 |
Why?
| | Cohort Studies | 4 | 2021 | 5729 | 0.150 |
Why?
| | Vaccination | 3 | 2021 | 1435 | 0.140 |
Why?
| | Insurance, Health | 1 | 2020 | 295 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 274 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 327 | 0.130 |
Why?
| | United States | 9 | 2022 | 15018 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 372 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 817 | 0.110 |
Why?
| | Retrospective Studies | 2 | 2021 | 15860 | 0.100 |
Why?
| | Prospective Studies | 2 | 2022 | 7639 | 0.090 |
Why?
| | Aged | 8 | 2022 | 24182 | 0.090 |
Why?
| | Treatment Outcome | 3 | 2021 | 10938 | 0.090 |
Why?
| | Middle Aged | 9 | 2022 | 33792 | 0.090 |
Why?
| | Mortality | 2 | 2021 | 359 | 0.070 |
Why?
| | Male | 9 | 2022 | 68216 | 0.060 |
Why?
| | Comorbidity | 2 | 2020 | 1655 | 0.060 |
Why?
| | Female | 9 | 2022 | 73913 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2022 | 3581 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2022 | 2861 | 0.050 |
Why?
| | Immunocompetence | 1 | 2022 | 44 | 0.050 |
Why?
| | Adolescent | 4 | 2021 | 21528 | 0.050 |
Why?
| | Prone Position | 1 | 2021 | 27 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 46 | 0.040 |
Why?
| | Organ Dysfunction Scores | 1 | 2021 | 50 | 0.040 |
Why?
| | Oximetry | 1 | 2021 | 114 | 0.040 |
Why?
| | Transplant Recipients | 1 | 2022 | 189 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2022 | 203 | 0.040 |
Why?
| | Young Adult | 3 | 2021 | 13322 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 308 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2021 | 59 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 131 | 0.040 |
Why?
| | Patient Positioning | 1 | 2021 | 69 | 0.040 |
Why?
| | Time Factors | 2 | 2021 | 6877 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 53 | 0.040 |
Why?
| | Vaccination Coverage | 1 | 2021 | 90 | 0.040 |
Why?
| | Managed Care Programs | 1 | 2020 | 140 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 209 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 856 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 239 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1084 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1285 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2021 | 552 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1497 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 447 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 662 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1800 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1757 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1486 | 0.030 |
Why?
| | RNA | 1 | 2022 | 928 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2088 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 785 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 861 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2022 | 2817 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 1137 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2734 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3274 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1185 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1637 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3459 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10398 | 0.020 |
Why?
|
|
Douin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|